Cargando…
Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile
The receptor-binding domains (RBDs) located in toxin A and toxin B of Clostridium difficile are known to be nontoxic and immunogenic. We need to develop a new type vaccine based on RBDs. In this study, we expressed and purified recombinant proteins (named RBD-TcdA and RBD-TcdB) as vaccine candidates...
Autores principales: | Luo, Deyan, Liu, Xuechao, Xing, Li, Sun, Yakun, Huang, Jie, Zhang, Liangyan, Li, Jiajia, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963439/ https://www.ncbi.nlm.nih.gov/pubmed/31717334 http://dx.doi.org/10.3390/vaccines7040180 |
Ejemplares similares
-
126 An Optimized, Synthetic DNA Vaccine Encoding the Toxin A and Toxin B Receptor Binding Domains of Clostridium difficile Induces Protective Antibody Responses In Vivo
por: Kutzler, Michele
Publicado: (2014) -
The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010) -
Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins
por: Shen, Aimee, et al.
Publicado: (2011) -
EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin
por: Schnell, Leonie, et al.
Publicado: (2016) -
Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
por: Matsuoka, Osamu, et al.
Publicado: (2017)